Comment on: Medicare and Medicaid Programs; Electronic Health Record Incentive Program–Stage 2

The following proposed rule has been released for public comment by Centers for Medicare & Medicaid Services (CMS): Medicare and Medicaid Programs; Electronic Health Record Incentive Program–Stage 2: http://www.regulations.gov/#!documentDetail;D=CMS-2012-0022-0001

Deadline: March 7 2012.

This proposed rule includes the Hepatitis clinical quality measure copied below.

Please review and provide comments according to the instructions – potentially including:

–          Whether you support the measures

–          Appropriateness of measures

–          Suggestions for other relevant hepatitis measures

–          Importance of retaining hepatitis quality measures in this document

Commenting Instructions

In commenting, please refer to file code CMS-0044-P. You may submit comments in one of four ways (please choose only one of the ways listed):

1. You may submit electronic comments on this regulation to www.regulations.gov. Follow the “Submit a comment” instructions.

2. You may mail written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-0044-P, P.O. Box 8013, Baltimore, MD 21244-8013. Please allow sufficient time for mailed comments to be received before the close of the comment period.

Proposed Hepatitis Measures

NQF – 0038

Title: Childhood Immunization Status

Description: Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); two H influenza type B (HiB); three hepatitis B (HepB); one chicken pox (VZV); four pneumococcal conjugate (PCV); two hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine and nine separate combination rates.

 

NQF – 0399

Title: Hepatitis C: Hepatitis A Vaccination in Patients with HCV

Description: Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who have received at least one injection of hepatitis A vaccine, or who have documented immunity to hepatitis A.

 

NQF – 0400

Title: Hepatitis C: Hepatitis B Vaccination in Patients with HCV

Description: Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who have received at least one injection of hepatitis B vaccine, or who have documented immunity to hepatitis B.

 

0401

Title: Hepatitis C: Counseling Regarding Risk of Alcohol Consumption

Description: Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who were counseled about the risks of alcohol use at least once within 12 months.

More Action Alerts Posts

Request for Signatures! Letter Urging Lift of Federal Ban on Funding for Syringe Exchange 

September 2, 2015

Recent outbreaks of HIV and Hepatitis C have spurred the House and Senate to reconsider lifting the federal ban funding for syringe exchange. Four key Republicans and Democrats, Hal Rogers (KY), Thad Cochran (MS), Nita Lowey (NY) and Barbara Mikulski (MD) are currently negotiating government funding bills. The Syringe Access Coalition has written letters to … Continue reading Request for Signatures! Letter Urging Lift of Federal Ban on Funding for Syringe Exchange 

read more »

Vote! For Vivian Huang, MD as EqualiTalks speaker @ 8th Annual Asian American Community Development Conference

August 29, 2015

NYC Hep B advocate and Charles B Wang Community Health Center medical provider Vivian Huang, MD, is a nominee to be an Inaugural EqualiTalks Speaker @ the 8th Annual Asian American Community Development Conference! Learn more, and Vote here: Vote for Vivian!  Inaugural EqualiTalks Speaker Nominees @ the 8th Annual Asian American Community Development Conference

read more »

Policy | Prescriber Prevails & Hep C in NYS

August 25, 2015

Expansion of Prescriber Prevails to cover Hep C medications would enable Medicaid patients to obtain anti-viral drugs for Hep C if prescribed by a medical provider. Read on about the bill, Governor Cuomo’s veto, and how you can support this legislation. Background “Prescriber Prevails” refers to a provision in New York State Medicaid law that gives … Continue reading Policy | Prescriber Prevails & Hep C in NYS

read more »

Comment! Concept Papers for New Employment & Education Services (HRA)

August 3, 2015

The New York City Human Resources Administration is proud to announce the release of four concept papers (CareerCompass, CareerBridge, CareerAdvance, and YouthPathways) detailing a new vision for employment and education services. See http://www1.nyc.gov/site/hra/business/concept-papers.page for the concept papers. The public comment period for concept papers will be open until September 18, 2015. We encourage written feedback … Continue reading Comment! Concept Papers for New Employment & Education Services (HRA)

read more »

Awareness | 3rd National African American Hep C Action Day – July 25, 2015

July 23, 2015

On July 25, 2013, the National Black Leadership Commission on AIDS, Inc. (NBLCA), in partnership with HARM Reduction Coalition and the Coalition on Positive Health Empowerment (C.O.P.E.), launched the First Annual African American Hepatitis C Action Day, a community mobilization initiative aimed at reducing the high incidence of HCV infection in black communities by drawing … Continue reading Awareness | 3rd National African American Hep C Action Day – July 25, 2015

read more »

Letter to Secretary of the Department of Health and Human Services on Recommendations for Action for Viral Hep

July 15, 2015

The Hepatitis Appropriations Partnership (HAP), Hep B United, and National Viral Hepatitis Roundtable (NVHR) Letter to Secretary of the Department of Health and Human Services (HHS), Sylvia Burwell (2014) See Letter: HAP HBU NVHR Letter to Secretary Burwell

read more »